| Nourished (n = 202) | Moderately malnourished (n = 115) | Severely malnourished (n = 98) | P value |
---|---|---|---|---|
Age (years, median, range) | 50 (25–75) | 54 (25–74) | 45 (26–75) | 0.2268 |
Surgical FIGO stage | Â | Â | Â | 0.0745 |
Stage 3 (n, %) | 175 (86.6%) | 98 (85.2%) | 75 (76.5%) | Â |
Stage 4 (n, %) | 27 (13.4%) | 17 (14.8%) | 23 (23.5%) | Â |
Histology | Â | Â | Â | 0.7059 |
Serous (n, %) | 166 (82.2%) | 89 (77.4%) | 75 (76.5%) | Â |
Endometrioid (n, %) | 22 (10.9%) | 15 (13.0%) | 11 (11.2%) | Â |
Mixed (n, %) | 6 (3.0%) | 5 (4.3%) | 4 (4.1%) | Â |
Clear cell (n, %) | 5 (2.5%) | 4 (3.5%) | 2 (2.0%) | Â |
Other (n, %) | 3 (1.5%) | 2 (1.7%) | 5 (5.1%) | Â |
Cytoreduction | Â | Â | Â | 0.0793 |
Optimal (n, %) | 177 (87.6%) | 97 (84.3%) | 76 (77.6%) | Â |
Sub-optimal (n, %) | 25 (12.4%) | 18 (15.7%) | 22 (22.4%) | Â |
Days to flatus (median, range) | 7 (4–10) | 7 (4–10) | 6.5 (4–10) | 0.7305 |
Days of hospitalization (median, range) | 12 (5–20) | 13 (5–20) | 12.5 (5–20) | 0.673 |
Serum albumin (g/L) (median, range) | 4.9 (3–6) | 3.3 (1–5.9) | 2.45 (1–4.8) | < 0.001 |
BMI at admission (median, range) | 27.9 (16.1–40) | 22.8 (16.1–39.6) | 20.15 (16–29.3) | < 0.001 |
BMI after surgery (median, range) | 25.9 (15.2–35) | 23.8 (15.2–30.9) | 21.05 (16–26) | < 0.001 |
NRI at admission (median, range) | 100 (97.5–108) | 92 (83.5–99.9) | 80.15 (75.5–91.4) | < 0.001 |
PFS (days, median, range) | 108 (20–200) | 90 (10–179) | 67.5 (10–120) | < 0.001 |
OS (days, median, range) | 240.5 (102–396) | 227 (100–357) | 207.5 (983–298) | < 0.001 |